-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, ST Wanbang (002082.SZ) announced that methylcobalamin independently developed by Wanbond Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, was recently certified as an orphan drug by the European Commission (EC) for the treatment of amyotrophic lateral sclerosis (ALS), also known as fever. Previously, methylcobalamin for the treatment of amyotrophic lateral sclerosis had been certified as an orphan drug by the US FDA.
Share
Listen to the news
Zhitong Finance App News, ST Wanbang (002082.SZ) announced that methylcobalamin independently developed by Wanbond Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, was recently certified as an orphan drug by the European Commission (EC) for the treatment of amyotrophic lateral sclerosis (ALS), also known as fever. Previously, methylcobalamin for the treatment of amyotrophic lateral sclerosis had been certified as an orphan drug by the US FDA.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending